Even though not many mutations are known in ovarian cancer cells, it is clear that the TGFβ signaling pathway is broadly active in ovarian cancer, as observed by high levels of pSMAD2 staining in different ovarian tumor types, and that its stimulation is important for ovarian cancer progression [25]. The gene discussed is TGFB1; the disease is ovarian neoplasm.